Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol and Progesterone in Hospitalized COVID-19 Patients
NCT04865029Phase 2Terminated
- Sponsor
- Tulane University
- Start
- Jul 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol, progesterone in coronavirus disease 2019 (COVID-19), sponsored by Tulane University. Started Jul 2021; status: terminated.
02
Drugs
estradiolprogesterone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04865029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04865029.